Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma.

MLA

Korthals, Mark, et al. “Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 19, no. 7, July 2013, pp. 1109–15. EBSCOhost, https://doi.org/10.1016/j.bbmt.2013.04.025.

APA

Korthals, M., Sehnke, N., Kronenwett, R., Schroeder, T., Strapatsas, T., Kobbe, G., Haas, R., & Fenk, R. (2013). Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 19(7), 1109–1115. https://doi.org/10.1016/j.bbmt.2013.04.025

Chicago

Korthals, Mark, Nina Sehnke, Ralf Kronenwett, Thomas Schroeder, Tobias Strapatsas, Guido Kobbe, Rainer Haas, and Roland Fenk. 2013. “Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 19 (7): 1109–15. doi:10.1016/j.bbmt.2013.04.025.